- Brady KT, Lydiard RB, Malcolm R, et al. Cocaineinduced psychosis. J Clin Psychiatry. 1991;52(12): 509-512.
- MMWR. Increasing morbidity and mortality associated with abuse of methamphetamine-United States, 1991-1994. MMWR Mart" Mortal WkIy Rep. 1995;44(47):882-886.
- Derlet RW, Rice P, Horowitz BZ, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7(2):157-161.
- Lowenstein DH, Massa SM, Rowbotham MC, et al. Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med. 1987;83(5):841-846.
- Rockwell DA, Ostwald P. Amphetamine use and abuse in psychiatric patients. Arch Gen Psychiatry. 1968;18:612-616.
- Bell DS. A comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry. 1965;3:701.
- Griffith JJ, Oates J, Cavanaugh J. Paranoid episodes induced by drugs. JAMA. 1968;205:39.
- Slater E. Book review of 'Amphetamine Psychosis," by P. H. Connell. Br Med J. 1959;488.
- Connell PH. Amphetamine Psychosis. Vol. 5. London: Oxford University Press; 1958.
- Angrist B, Sathananthan G, WiIk S, et al. Amphetamine psychosis: behavioral and biochemical aspects. J Psycbiatr Res. 1974;11:13-23.
- Janowsky DS, Risch C. Amphetamine psychosis and psychotic symptoms. Psychopharmacology. 1979;65:73-77.
- Sato M, Chen CC, Akiyama K, et al. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry. 1983;18:429440.
- Shaner A, Roberts LJ, Eckman TA, et al. Sources of diagnostic uncertainty for chronically psychotic cocaine abusers. Psychiatr Sew. 1998;49(5):684690.
- Angrist B, Rotrosen J, Gershon S. Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology (Bert). 1980;72(1):17-19.
- Angrist BM, Gershon S. The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry. 1970; 2(2):95-107.
- Janowsky DS, Davis JM. Methyiphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. Arch Gen Psychiatry. 1976;33(3):304-308.
- Sato M. Experimental study of onset and relapsing mechanisms of chronic methamphetamine psychosis. Psychiatria et Neurologia Japonica. 1979; 81:21-32.
- Flaum M, Schultz SK. When does amphetamineinduced psychosis become schizophrenia? Am J Psychiatry. 1996;153(6):812-815.
- Sherer MA, Kumor KM, Crone EJ, et al. Suspiciousness induced by four-hour intravenous infusions of cocaine. Arch Gen Psychiatry. 1988;45: 673-677.
- Palermo GB, Palermo MT. Clinical diagnostic considerations on cocaine abuse. J Psychoactive Drugs. 1990;22(3):313-318.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
- Batki SL, Manfredi LB, Jacob PD, et al. Fluoxetine for cocaine dependence in methadone maintenance: quantitative plasma and urine cocaine/ benzoylecgonine concentrations. J Clin Psychopharmacol. 1993;13(4):243-250.
- Gawin FH, Kleber HD. Cocaine abuse treatment: open pilot trial with despiramine and lithium carbonate. Arch Gen Psychiatry. 1984;41:903-909.
- First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-Patient Edition (SCID-I/P, Version 2.0). New York: Biometrics Research Department; 1995.
- Kay SR, Fizbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizopbr Bull. 1987;13:261-276.
- Overall JE, Gorham DR. The brief psychiatrie rating scale. Psychol Rep. 1962;10:799-812.
- Gerlach J, Korsgaard S, Clemmesen P, et al. The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity. Acta Psychiatr Scand. 1993;87(4):244-252.
- Hollister LE. Clinical Use of Psychotherapeutic Drugs. Springfield, IL Charles C. Thomas; 1973.
- Hayashi T, Tadokoro S. Parallelism between avoidance-suppressing and prolactin-increasing effects of antipsychotic drugs in rats. Jpn J Pharmacol. 1984;35:451-456.
- Kay SR. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Vol. 5. New York: Brunner/Mazel; 1991.
- Serper MR, Alpert M, Richardson NA, et al. Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry. 1995; 152(10): 1464-1469.
- Harris D, Wolkowitz O, Batki SL. Preliminary analysis of plasma cortisol in cocaine dependence: treatment with fluoxetine or placebo. In: Harris LS, ed. Problems of Drug Dependence 1995. Proceedings of the 57th Annual Scientific Meeting, the College on the Problems of Drug Dependence. NIDA Research Monograph Series. Scottsdale, Ariz: U.S. Government Printing Office; 1995.
- Kennedy JA, Hartman N, Sbriglio R, et al. Metyrapone-induced withdrawal symptoms. Br J Addict. 1990;85(9):1133-1140.
- Frederick SL, Reus VI, Ginsberg D, et al. Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers. Biol Psychiatry. 1998, Apr 1; 43(7): 525-530.
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.